Thanks, I watched it. I actually thought it was very good. Otto Yang is a stud - no BS for sure - and anyone who doubts that the drug provides benefit should listen to him. I also thought Scott Kelly was very impressive and did a great job - smooth and has total command of the drug, the science, etc. He should be the face man without question.

Sounds like late June for a long haulers data. Even if it doesn’t move the market, it will be some great new information for us, so that is exciting.